EIF4E and cancer: We interpret this to suggest that cancers with high eIF4E activity may indeed have been sensitive to everolimus, as suggested by our in vitro data, but that the cells remaining after two weeks of drug treatment reflect selection to acquire drug resistance by changing the pathways regulating eIF4E function.